{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:39:33Z","timestamp":1784720373189,"version":"3.55.0"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001661","name":"Universit\u00e4t Heidelberg","doi-asserted-by":"publisher","award":["F.206871"],"award-info":[{"award-number":["F.206871"]}],"id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejpn.2025.03.017","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:04:09Z","timestamp":1745499849000},"page":"84-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Newborn screening for neuro-metabolic disorders: Strategies, clinical benefits, and prerequisites for program expansion"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4251-7257","authenticated-orcid":false,"given":"Ulrike","family":"M\u00fctze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2619-8727","authenticated-orcid":false,"given":"Svenja","family":"Scharr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4342-1805","authenticated-orcid":false,"given":"Elena","family":"Schnabel-Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6576-6566","authenticated-orcid":false,"given":"Oya","family":"Kuseyri H\u00fcbschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"H\u00f6ster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7210-2503","authenticated-orcid":false,"given":"Ali Tun\u04ab","family":"Tuncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5188-9477","authenticated-orcid":false,"given":"Stefan","family":"K\u00f6lker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Opladen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejpn.2025.03.017_bib1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-0444","article-title":"Long-term outcomes of individuals with metabolic diseases identified through newborn screening","volume":"146","author":"M\u00fctze","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2025.03.017_bib2","doi-asserted-by":"crossref","unstructured":"U. M\u00fctze, et al., Long-term outcomes of adolescents and young adults identified by metabolic newborn screening, Pediatrics 155 (4) (2025) e2024068293. doi: 10.1542\/peds.2024-068293. PMID: 40101767.","DOI":"10.1542\/peds.2024-068293"},{"issue":"6 Pt 1","key":"10.1016\/j.ejpn.2025.03.017_bib3","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1542\/peds.111.6.1399","article-title":"Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications","volume":"111","author":"Schulze","year":"2003","journal-title":"Pediatrics"},{"issue":"23","key":"10.1016\/j.ejpn.2025.03.017_bib4","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa025225","article-title":"Screening newborns for inborn errors of metabolism by tandem mass spectrometry","volume":"348","author":"Wilcken","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.ejpn.2025.03.017_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/nu15153355","article-title":"Combined newborn screening allows comprehensive identification also of attenuated phenotypes for methylmalonic acidurias and homocystinuria","volume":"15","author":"Schnabel","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcf.2013.06.003","article-title":"Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations","volume":"13","author":"Sommerburg","year":"2014","journal-title":"J. Cyst. Fibros."},{"issue":"9","key":"10.1016\/j.ejpn.2025.03.017_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184897","article-title":"Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: second-tier LC-MS\/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders","volume":"12","author":"Monostori","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283024","article-title":"A high-throughput newborn screening approach for SCID, SMA, and SCD combining multiplex qPCR and tandem mass spectrometry","volume":"18","author":"Tesorero","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpn.2025.03.017_bib9","series-title":"Principles of Screening for Disease","author":"Wilson","year":"1968"},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib10","first-page":"62","article-title":"Wilson and jungner revisited: are screening criteria fit for the 21st century?","volume":"10","author":"Schnabel-Besson","year":"2024"},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijns7010015","article-title":"Neonatal screening in Europe revisited: an ISNS perspective on the current state and developments since 2010","volume":"7","author":"Loeber","year":"2021","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib12","first-page":"38","volume":"10","author":"Therrell","year":"2024","journal-title":"Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020\u20132023)"},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jimd.12370","article-title":"Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: first revision","volume":"44","author":"Forny","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.03.017_bib150","first-page":"29","article-title":"Networking across borders for individuals with organic acidurias and urea cycle disorders: the E-IMD consortium","volume":"22","author":"K\u00f6lker","year":"2015","journal-title":"JIMD Rep"},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib149","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13023-021-01726-3","article-title":"U-IMD: the first Unified European registry for inherited metabolic diseases","volume":"16","author":"Opladen","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ejpn.2025.03.017_bib17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/jimd.12731","article-title":"Outcomes after newborn screening for propionic and methylmalonic acidemia and homocystinurias","volume":"47","author":"Reischl-Hajiabadi","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10545-015-9907-8","article-title":"Impact of age at onset and newborn screening on outcome in organic acidurias","volume":"39","author":"Heringer","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib157","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10545-011-9419-0","article-title":"Propionic acidemia: neonatal versus selective metabolic screening","volume":"35","author":"Gr\u00fcnert","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10545-016-9979-0","article-title":"Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency","volume":"40","author":"Morris","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib151","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jimd.12041","article-title":"Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: data from the E-HOD registry","volume":"42","author":"Huemer","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ejpn.2025.03.017_bib37","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jimd.12099","article-title":"Natural history, with clinical, biochemical, and molecular characterization of classical homocystinuria in the Qatari population","volume":"42","author":"Al-Dewik","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"10.1016\/j.ejpn.2025.03.017_bib39","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1023\/A:1005445132327","article-title":"Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control","volume":"21","author":"Yap","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6030060","article-title":"Long-term outcomes of adult patients with homocystinuria before and after newborn screening","volume":"6","author":"Yamada","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-016-9991-4","article-title":"Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency","volume":"40","author":"Huemer","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/gim.2015.45","article-title":"Outcomes of four patients with homocysteine remethylation disorders detected by newborn screening","volume":"18","author":"Wong","year":"2016","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13023-020-01485-7","article-title":"Variable phenotypes and outcomes associated with the MMACHC c.609G>A homologous mutation: long term follow-up in a large cohort of cases","volume":"15","author":"He","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/jimd.12171","article-title":"Early neurodevelopmental characterization in children with cobalamin C\/defect","volume":"43","author":"Ricci","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.03.017_bib158","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jpeds.2021.02.009","article-title":"Health outcomes of infants with vitamin B(12) deficiency identified by newborn screening and early treated","volume":"235","author":"M\u00fctze","year":"2021","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib50","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-064809","article-title":"Vitamin B12 deficiency newborn screening","volume":"154","author":"M\u00fctze","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpn.2025.03.017_bib159","series-title":"Newborn Screening in Your State","year":"2024"},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib61","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"H\u00e4berle","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1\u20132","key":"10.1016\/j.ejpn.2025.03.017_bib152","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"A longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw","year":"2014","journal-title":"Mol. Genet. Metabol."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib81","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1542\/peds.2008-0586","article-title":"Expanded newborn screening: outcome in screened and unscreened patients at age 6 years","volume":"124","author":"Wilcken","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib160","first-page":"721","article-title":"Long-term follow-up of children with carbamoyl phosphate synthase 1 deficiency detected in newborn screening","volume":"52","author":"Zhang","year":"2023","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"5","key":"10.1016\/j.ejpn.2025.03.017_bib82","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10545-016-9938-9","article-title":"Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders","volume":"39","author":"Posset","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib83","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.25492","article-title":"Impact of diagnosis and therapy on cognitive function in urea cycle disorders","volume":"86","author":"Posset","year":"2019","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2025.03.017_bib88","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ymgme.2020.10.013","article-title":"Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders","volume":"131","author":"Posset","year":"2020","journal-title":"Mol. Genet. Metabol."},{"issue":"1\u20132","key":"10.1016\/j.ejpn.2025.03.017_bib89","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymgme.2014.07.003","article-title":"Biochemical and molecular characteristics of patients with organic acidaemias and urea cycle disorders identified through newborn screening","volume":"113","author":"Barends","year":"2014","journal-title":"Mol. Genet. Metabol."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib91","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ymgme.2010.01.013","article-title":"Long-term outcome of patients with argininosuccinate lyase deficiency diagnosed by newborn screening in Austria","volume":"100","author":"Mercimek-Mahmutoglu","year":"2010","journal-title":"Mol. Genet. Metabol."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib161","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ymgme.2009.06.011","article-title":"Argininosuccinate lyase deficiency: longterm outcome of 13 patients detected by newborn screening","volume":"98","author":"Ficicioglu","year":"2009","journal-title":"Mol. Genet. Metabol."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib95","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-020-01379-8","article-title":"Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH(4)) deficiencies","volume":"15","author":"Opladen","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib94","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1038\/s41467-021-25515-5","article-title":"Insights into the expanding phenotypic spectrum of inherited disorders of biogenic amines","volume":"12","author":"Kuseyri H\u00fcbschmann","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108148","article-title":"Newborn screening for aromatic l-amino acid decarboxylase deficiency - strategies, results, and implication for prevalence calculations","volume":"141","author":"Reischl-Hajiabadi","year":"2024","journal-title":"Mol. Genet. Metabol."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib162","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymgme.2021.03.009","article-title":"Detection of 3-O-methyldopa in dried blood spots for neonatal diagnosis of aromatic L-amino-acid decarboxylase deficiency: the northeastern Italian experience","volume":"133","author":"Burlina","year":"2021","journal-title":"Mol. Genet. Metabol."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib102","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jimd.12649","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency: requirements for safe application and knowledge-generating follow-up","volume":"47","author":"Roubertie","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib98","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-016-0522-z","article-title":"Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency","volume":"12","author":"Wassenberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib109","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2013.10.018","article-title":"Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring","volume":"111","author":"Stockler-Ipsiroglu","year":"2014","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejpn.2025.03.017_bib163","unstructured":"CreatineInfo. CreatineInfo. [cited 2024 18.10.2024]."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib106","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-062100","article-title":"Evidence and recommendation for guanidinoacetate methyltransferase deficiency newborn screening","volume":"152","author":"Ream","year":"2023","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.ejpn.2025.03.017_bib164","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jcyt.2024.03.487","article-title":"Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States","volume":"26","author":"Adang","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ejpn.2025.03.017_bib165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejpn.2024.03.003","article-title":"Newborn screening in metachromatic leukodystrophy - European consensus-based recommendations on clinical management","volume":"49","author":"Laugwitz","year":"2024","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"10322","key":"10.1016\/j.ejpn.2025.03.017_bib126","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib166","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/cge.13546","article-title":"Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients","volume":"96","author":"Germain","year":"2019","journal-title":"Clin. Genet."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13023-022-02392-9","article-title":"Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry","volume":"17","author":"Beck","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ijns9020031","article-title":"Newborn screening for Fabry disease: current status of knowledge","volume":"9","author":"Gragnaniello","year":"2023","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib167","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10897-015-9879-8","article-title":"Newborn screening for lysosomal storage disorders: views of genetic healthcare providers","volume":"25","author":"Lisi","year":"2016","journal-title":"J Genet Couns"},{"key":"10.1016\/j.ejpn.2025.03.017_bib168","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16383","article-title":"Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024","author":"Schoser","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib169","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/ene.13285","article-title":"European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience","volume":"24","author":"van der Ploeg","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2025.03.017_bib114","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jpeds.2014.10.068","article-title":"Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth","volume":"166","author":"Chien","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejpn.2025.03.017_bib170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpeds.2021.12.072","article-title":"Outcome of later-onset Pompe disease identified through newborn screening","volume":"244","author":"Lee","year":"2022","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib171","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2007.01.011","article-title":"The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I","volume":"91","author":"Pastores","year":"2007","journal-title":"Mol. Genet. Metabol."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib172","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41409-022-01886-1","article-title":"Long term follow-up after haematopoietic stem cell transplantation for mucopolysaccharidosis type I-H: a retrospective study of 51 patients","volume":"58","author":"Gardin","year":"2023","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.ejpn.2025.03.017_bib131","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2009.01.020","article-title":"Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome","volume":"15","author":"Boelens","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib132","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad","year":"2010","journal-title":"Semin. Hematol."},{"issue":"5","key":"10.1016\/j.ejpn.2025.03.017_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/jimd.12508","article-title":"How longitudinal observational studies can guide screening strategy for rare diseases","volume":"45","author":"M\u00fctze","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"10.1016\/j.ejpn.2025.03.017_bib15","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1373\/clinchem.2007.087775","article-title":"Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry","volume":"53","author":"la Marca","year":"2007","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.ejpn.2025.03.017_bib16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1515\/jpem-2022-0340","article-title":"Newborn screening for propionic, methylmalonic acidemia and vitamin B12 deficiency. Analysis of 588,793 newborns","volume":"35","author":"Mart\u00edn-Rivada","year":"2022","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jimd.12297","article-title":"Delineating the clinical spectrum of isolated methylmalonic acidurias: cblA and mut","volume":"44","author":"H\u00f6rster","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10545-015-9839-3","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation","volume":"38","author":"K\u00f6lker","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10545-015-9840-x","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype","volume":"38","author":"K\u00f6lker","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jimd.12193","article-title":"Retrospective evaluation of the Dutch pre-newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: what to aim, expect, and evaluate from newborn screening?","volume":"43","author":"Haijes","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.03.017_bib22","unstructured":"!!! INVALID CITATION !!! [16]."},{"key":"10.1016\/j.ejpn.2025.03.017_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1172-8-6","article-title":"Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients","volume":"8","author":"Gr\u00fcnert","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/jimd.12613","article-title":"Safety, efficacy, and timing of transplantation(s) in propionic and methylmalonic aciduria","volume":"46","author":"Chakrapani","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jimd.12318","article-title":"Liver and\/or kidney transplantation in amino and organic acid-related inborn errors of metabolism: an overview on European data","volume":"44","author":"Molema","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ejpn.2025.03.017_bib27","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1007\/s12325-020-01305-1","article-title":"Post-transplantation outcomes in patients with PA or MMA: a review of the literature","volume":"37","author":"Yap","year":"2020","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib28","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1038\/s41467-024-47460-9","article-title":"Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria","volume":"15","author":"Baek","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jimd.12665","article-title":"Gene therapy for organic acidemias: lessons learned from methylmalonic and propionic acidemia","volume":"47","author":"Chandler","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10545-015-9830-z","article-title":"Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines","volume":"38","author":"Huemer","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jimd.12034","article-title":"Newborn screening for homocystinurias: recent recommendations versus current practice","volume":"42","author":"Keller","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib33","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1021\/acs.analchem.2c03098","article-title":"Development of a universal second-tier newborn screening LC-MS\/MS method for amino acids, lysophosphatidylcholines, and organic acids","volume":"95","author":"Kilgore","year":"2023","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13023-021-01784-7","article-title":"Implementation of second-tier tests in newborn screening for the detection of vitamin B(12) related acquired and genetic disorders: results on 258,637 newborns","volume":"16","author":"Pajares","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.ejpn.2025.03.017_bib35","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1373\/clinchem.2010.148957","article-title":"Determination of total homocysteine, methylmalonic acid, and 2-methylcitric acid in dried blood spots by tandem mass spectrometry","volume":"56","author":"Turgeon","year":"2010","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib36","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jimd.12338","article-title":"Cystathionine \u03b2-synthase deficiency in the E-HOD registry-part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis","volume":"44","author":"Ko\u017eich","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2013.4915","article-title":"Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency","volume":"71","author":"Diekman","year":"2014","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2025.03.017_bib42","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jimd.12504","article-title":"Influence of early identification and therapy on long-term outcomes in early-onset MTHFR deficiency","volume":"45","author":"Yverneau","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-2007-973067","article-title":"[A rare inborn error of intracellular processing of cobalamine presenting with microcephalus and megaloblastic anemia: a report of 3 children]","volume":"219","author":"M\u00fcller","year":"2007","journal-title":"Klin. P\u00e4diatr."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10545-010-9120-8","article-title":"Isolated remethylation disorders: do our treatments benefit patients?","volume":"34","author":"Schiff","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib46","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jimd.12671","article-title":"Collaborative evaluation study on 18 candidate diseases for newborn screening in 1.77 million samples","volume":"46","author":"Maier","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ejpn.2025.03.017_bib47","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10545-014-9687-6","article-title":"Clinical presentation and outcome in a series of 88 patients with the cblC defect","volume":"37","author":"Fischer","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.03.017_bib51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jpeds.2019.07.052","article-title":"Newborn screening for vitamin B(12) deficiency in Germany-strategies, results, and public health implications","volume":"216","author":"Gramer","year":"2020","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00112-014-3297-0","article-title":"Neue Zielerkrankungen im Neugeborenenscreening","volume":"163","author":"R\u00f6schinger","year":"2015","journal-title":"Monatsschr. Kinderheilkd."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib53","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpeds.2010.03.006","article-title":"Maternal and neonatal vitamin B12 deficiency detected through expanded newborn screening--United States, 2003-2007","volume":"157","author":"Hinton","year":"2010","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejpn.2025.03.017_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2021.02.009","article-title":"Health outcomes of infants with vitamin B12 deficiency identified by newborn screening and early treated","author":"M\u00fctze","year":"2021","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejpn.2025.03.017_bib55","series-title":"Clinical Outcomes and Survival of Individuals with Methylmalonic Acidemia, Propionic Acidemia, Classic Homocystinuria, and Remethylation Disorders Identified through Newborn Screening","author":"Reischl-Hajiabadi","year":"2023"},{"key":"10.1016\/j.ejpn.2025.03.017_bib56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-015-0266-1","article-title":"Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients","volume":"10","author":"Brassier","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10545-015-9901-1","article-title":"Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders--review and meta-analysis of observational studies published over more than 35 years","volume":"39","author":"Burgard","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib58","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1203\/PDR.0b013e3181a27a16","article-title":"Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders","volume":"66","author":"Krivitzky","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ejpn.2025.03.017_bib59","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13023-014-0187-4","article-title":"Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases","volume":"9","author":"Mart\u00edn-Hern\u00e1ndez","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib60","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13023-016-0493-0","article-title":"Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013","volume":"11","author":"Unsinn","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000100393","article-title":"Development, validation and application of tandem mass spectrometry for screening of inborn metabolic disorders in Kuwaiti infants","volume":"16","author":"Abdel-Hamid","year":"2007","journal-title":"Med. Princ. Pract."},{"issue":"Suppl 1","key":"10.1016\/j.ejpn.2025.03.017_bib63","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1177\/0883073899014001021","article-title":"Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism","volume":"14","author":"Naylor","year":"1999","journal-title":"J. Child Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib64","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00431-003-1177-z","article-title":"Neonatal screening for citrullinaemia","volume":"162","author":"Sander","year":"2003","journal-title":"Eur. J. Pediatr."},{"issue":"5","key":"10.1016\/j.ejpn.2025.03.017_bib65","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jpba.2009.03.001","article-title":"Hypocitrullinemia in expanded newborn screening by LC-MS\/MS is not a reliable marker for ornithine transcarbamylase deficiency","volume":"49","author":"Cavicchi","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib66","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ajmg.c.31996","article-title":"Proximal urea cycle defects are challenging to detect with newborn screening: results of a prospective pilot study using post-analytical tools","volume":"190","author":"Hall","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"10.1016\/j.ejpn.2025.03.017_bib67","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1373\/49.4.681","article-title":"Quantification of glutamine in dried blood spots and plasma by tandem mass spectrometry for the biochemical diagnosis and monitoring of ornithine transcarbamylase deficiency","volume":"49","author":"Trinh","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejpn.2025.03.017_bib68","first-page":"47","article-title":"m.8993T>G-Associated leigh syndrome with hypocitrullinemia on newborn screening","volume":"17","author":"Mori","year":"2014","journal-title":"JIMD Rep"},{"issue":"1\u20132","key":"10.1016\/j.ejpn.2025.03.017_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2021.06.007","article-title":"Prospective diagnosis of MT-ATP6-related mitochondrial disease by newborn screening","volume":"134","author":"Peretz","year":"2021","journal-title":"Mol. Genet. Metabol."},{"issue":"12","key":"10.1016\/j.ejpn.2025.03.017_bib70","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/gim.2014.62","article-title":"Postanalytical tools improve performance of newborn screening by tandem mass spectrometry","volume":"16","author":"Hall","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejpn.2025.03.017_bib71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cca.2014.05.016","article-title":"Development of an assay to simultaneously measure orotic acid, amino acids, and acylcarnitines in dried blood spots","volume":"436","author":"Held","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2018.04.006","article-title":"Newborn screening for proximal urea cycle disorders: current evidence supporting recommendations for newborn screening","volume":"124","author":"Merritt","year":"2018","journal-title":"Mol. Genet. Metabol."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib73","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/jimd.12331","article-title":"The role of orotic acid measurement in routine newborn screening for urea cycle disorders","volume":"44","author":"Staretz-Chacham","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.03.017_bib74","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cca.2014.05.024","article-title":"High-throughput tandem mass spectrometry multiplex analysis for newborn urinary screening of creatine synthesis and transport disorders, Triple H syndrome and OTC deficiency","volume":"436","author":"Auray-Blais","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"Suppl 3","key":"10.1016\/j.ejpn.2025.03.017_bib75","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1007\/s10545-010-9148-9","article-title":"Diagnosis and high incidence of hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome in northern Saskatchewan","volume":"33","author":"Sokoro","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ejpn.2025.03.017_bib76","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ymgme.2017.06.003","article-title":"Newborn screening for hyperargininemia due to arginase 1 deficiency","volume":"121","author":"Therrell","year":"2017","journal-title":"Mol. Genet. Metabol."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib77","article-title":"Insights into national laboratory newborn screening and future prospects","volume":"58","author":"Mujamammi","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib78","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpeds.2012.06.065","article-title":"Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ","volume":"162","author":"Ah Mew","year":"2013","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib79","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00431-003-1188-9","article-title":"Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation","volume":"162","author":"Bachmann","year":"2003","journal-title":"Eur. J. Pediatr."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib80","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ymgme.2014.12.435","article-title":"An audit of newborn screening procedure: impact on infants presenting clinically before results are available","volume":"114","author":"Tal","year":"2015","journal-title":"Mol. Genet. Metabol."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib84","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-017-0661-x","article-title":"Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland","volume":"12","author":"Nettesheim","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib85","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/jimd.12047","article-title":"Argininosuccinic aciduria: recent pathophysiological insights and therapeutic prospects","volume":"42","author":"Baruteau","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ejpn.2025.03.017_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6040077","article-title":"Considering proximal urea cycle disorders in expanded newborn screening","volume":"6","author":"Vasquez-Loarte","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"4","key":"10.1016\/j.ejpn.2025.03.017_bib87","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10545-016-9942-0","article-title":"Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium","volume":"39","author":"Waisbren","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2025.03.017_bib90","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1172-6-44","article-title":"Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany","volume":"6","author":"Lindner","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-013-9624-0","article-title":"Cross-sectional observational study of 208 patients with non-classical urea cycle disorders","volume":"37","author":"R\u00fcegger","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.ejpn.2025.03.017_bib93","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1007\/s10545-010-9106-6","article-title":"Expanded newborn screening: reducing harm, assessing benefit","volume":"33","author":"Wilcken","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib96","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/BJ20110293","article-title":"Tetrahydrobiopterin: biochemistry and pathophysiology","volume":"438","author":"Werner","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejpn.2025.03.017_bib97","series-title":"Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases","first-page":"3","article-title":"Disorders of phenylalanine and tetrahydrobiopterin metabolism","author":"Blau","year":"2014"},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib99","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10545-009-1076-1","article-title":"Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up","volume":"32","author":"Manegold","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107624","article-title":"Prevalence of DDC genotypes in patients with aromatic L-amino acid decarboxylase (AADC) deficiency and in silico prediction of structural protein changes","volume":"139","author":"Himmelreich","year":"2023","journal-title":"Mol. Genet. Metabol."},{"issue":"5","key":"10.1016\/j.ejpn.2025.03.017_bib101","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/jimd.12247","article-title":"AADC deficiency from infancy to adulthood: symptoms and developmental outcome in an international cohort of 63 patients","volume":"43","author":"Pearson","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"9","key":"10.1016\/j.ejpn.2025.03.017_bib103","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114712","article-title":"Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease","volume":"13","author":"Hwu","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib104","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/jimd.12208","article-title":"High throughput newborn screening for aromatic L-amino-acid decarboxylase deficiency by analysis of concentrations of 3-O-methyldopa from dried blood spots","volume":"43","author":"Brennenstuhl","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib107","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1212\/01.wnl.0000234852.43688.bf","article-title":"GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis","volume":"67","author":"Mercimek-Mahmutoglu","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2025.03.017_bib108","series-title":"GeneReviews((R))","article-title":"Creatine deficiency disorders","author":"Mercimek-Andrews","year":"1993"},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10545-013-9662-7","article-title":"Feasibility of newborn screening for guanidinoacetate methyltransferase (GAMT) deficiency","volume":"37","author":"Pasquali","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8","key":"10.1016\/j.ejpn.2025.03.017_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081902","article-title":"Highlights on genomics applications for lysosomal storage diseases","volume":"9","author":"La Cognata","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejpn.2025.03.017_bib113","series-title":"GeneReviews","article-title":"Pompe disease","author":"Leslie","year":"1993"},{"key":"10.1016\/j.ejpn.2025.03.017_bib115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpeds.2015.10.078","article-title":"Very early treatment for infantile-onset Pompe disease contributes to better outcomes","volume":"169","author":"Yang","year":"2016","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib116","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib117","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.2007-2222","article-title":"Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program","volume":"122","author":"Chien","year":"2008","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib118","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jpeds.2010.11.053","article-title":"Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening","volume":"158","author":"Chien","year":"2011","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib119","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns6010009","article-title":"The first year experience of newborn screening for Pompe disease in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.ejpn.2025.03.017_bib120","article-title":"Newborn screening for Pompe disease in Italy: long-term results and future challenges","volume":"33","author":"Gragnaniello","year":"2022","journal-title":"Mol Genet Metab Rep"},{"issue":"4","key":"10.1016\/j.ejpn.2025.03.017_bib121","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ymgme.2011.09.002","article-title":"Newborn screening for Pompe disease in Japan","volume":"104","author":"Oda","year":"2011","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejpn.2025.03.017_bib122","article-title":"An analysis of Pompe newborn screening data: a new prevalence at birth, insight and discussion","volume":"11","author":"Colburn","year":"2023","journal-title":"Front Pediatr"},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib123","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10545-018-0159-2","article-title":"Newborn screening for Pompe disease: impact on families","volume":"41","author":"Pruniski","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.ejpn.2025.03.017_bib124","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jnr.23792","article-title":"Gene therapy for metachromatic leukodystrophy","volume":"94","author":"Rosenberg","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejpn.2025.03.017_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2023.06.005","article-title":"Metachromatic leukodystrophy: to screen or not to screen?","volume":"46","author":"Jonckheere","year":"2023","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2025.03.017_bib127","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41436-020-01017-5","article-title":"Toward newborn screening of metachromatic leukodystrophy: results from analysis of over 27,000 newborn dried blood spots","volume":"23","author":"Hong","year":"2021","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108349","article-title":"Improving newborn screening test performance for metachromatic leukodystrophy: recommendation from a pre-pilot study that identified a late-infantile case for treatment","volume":"142","author":"Wu","year":"2024","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejpn.2025.03.017_bib129","series-title":"GeneReviews","article-title":"Mucopolysaccharidosis type I","author":"Clarke","year":"1993"},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib133","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","article-title":"Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri","volume":"166","author":"Hopkins","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejpn.2025.03.017_bib134","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","article-title":"Newborn screening for lysosomal storage disorders in Illinois: the initial 15-month experience","volume":"190","author":"Burton","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejpn.2025.03.017_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2023.113644","article-title":"First three years' experience of mucopolysaccharidosis type-I newborn screening in California","volume":"263","author":"Fillman","year":"2023","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib136","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2017.03.001","article-title":"Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: three-year findings from a screening program in a closed Mexican health system","volume":"121","author":"Navarrete-Martinez","year":"2017","journal-title":"Mol. Genet. Metabol."},{"issue":"Suppl 2","key":"10.1016\/j.ejpn.2025.03.017_bib137","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13052-018-0552-3","article-title":"Newborn screening in mucopolysaccharidoses","volume":"44","author":"Donati","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.ejpn.2025.03.017_bib138","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1750-1172-8-147","article-title":"A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan","volume":"8","author":"Lin","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejpn.2025.03.017_bib139","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib142","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ymgme.2017.06.002","article-title":"Functional and biological studies of \u03b1-galactosidase A variants with uncertain significance from newborn screening in Taiwan","volume":"123","author":"Liao","year":"2018","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejpn.2025.03.017_bib143","article-title":"Newborn screening for Fabry disease in the western region of Japan","volume":"22","author":"Sawada","year":"2020","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib144","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13023-020-1319-7","article-title":"3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces","volume":"15","author":"Gr\u00fcnert","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejpn.2025.03.017_bib145","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12750","article-title":"Comparative analysis of gene and disease selection in genomic newborn screening studies","author":"Betzler","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ejpn.2025.03.017_bib146","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jimd.12364","article-title":"Newborn screening and disease variants predict neurological outcome in isovaleric aciduria","volume":"44","author":"M\u00fctze","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ejpn.2025.03.017_bib147","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00431-022-04421-y","article-title":"Sudden neonatal death in individuals with medium-chain acyl-coenzyme A dehydrogenase deficiency: limit of newborn screening","volume":"181","author":"M\u00fctze","year":"2022","journal-title":"Eur. J. Pediatr."},{"issue":"4","key":"10.1016\/j.ejpn.2025.03.017_bib148","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/acn3.52002","article-title":"Neurological outcome in long-chain hydroxy fatty acid oxidation disorders","volume":"11","author":"M\u00fctze","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"10.1016\/j.ejpn.2025.03.017_bib153","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00103-023-03772-7","article-title":"[Evaluation and optimization of newborn screening by structured long-term follow-up-using the example of inherited metabolic diseases]","volume":"66","author":"M\u00fctze","year":"2023","journal-title":"Bundesgesundheitsblatt - Gesundheitsforsch. - Gesundheitsschutz"},{"issue":"1","key":"10.1016\/j.ejpn.2025.03.017_bib154","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s13063-017-2327-3","article-title":"Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys","volume":"18","author":"Potter","year":"2017","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.ejpn.2025.03.017_bib155","article-title":"Core outcome sets for medium-chain acyl-CoA dehydrogenase deficiency and phenylketonuria","volume":"148","author":"Pugliese","year":"2021"},{"key":"10.1016\/j.ejpn.2025.03.017_bib156","article-title":"Impact of early diagnosis, disease variant, and quality of care on the neurocognitive outcome in maple syrup urine disease: a meta-analysis","author":"Scharre","year":"2024","journal-title":"Genet. Med."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379825000637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379825000637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:39:04Z","timestamp":1762364344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379825000637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":172,"alternative-id":["S1090379825000637"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2025.03.017","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newborn screening for neuro-metabolic disorders: Strategies, clinical benefits, and prerequisites for program expansion","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2025.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}